Hilltop National Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
+7,577
New +$1.43M 0.31% 77
2026
Q1
Sell
-6,092
Closed -$1.12M 799
2025
Q4
$1.12M Buy
6,092
+3,793
+165% +$665K 0.27% 97
2025
Q3
$353K Hold
2,299
0.09% 169
2025
Q2
$321K Buy
+2,299
New +$322K 0.08% 173
2024
Q4
$384K Sell
2,933
-15
-0.5% -$2.1K 0.12% 146
2024
Q3
$459K Hold
2,948
0.14% 137
2024
Q2
$460K Buy
2,948
+24
+0.8% +$3.61K 0.15% 144
2024
Q1
$396K Buy
+2,924
New +$387K 0.13% 155

Other funds holding AZN

Hilltop National Bank's AZN Position: Q2 2026 in Review

Hilltop National Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 7,577 shares worth $1.44M. The stake represents 0.31% of the portfolio and ranks #77 among its holdings. This is a return to the name: Hilltop National Bank previously reported a position in AZN as recently as Q4 2025.

Hilltop National Bank first reported a position in AZN in Q1 2024 and has held it in 8 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hilltop National Bank held 7,577 shares of AstraZeneca worth $1.44M as of Q2 2026.
  • AstraZeneca was a new Hilltop National Bank position in Q2 2026.
  • AstraZeneca made up 0.31% of Hilltop National Bank's portfolio in Q2 2026, its #77 holding.
  • Hilltop National Bank first reported a position in AstraZeneca in Q1 2024 and has held it in 8 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.